Hohimer Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-471
| Closed | -$234K | – | 299 |
|
|
2025
Q1 | $234K | Hold |
471
| – | – | 0.05% | 219 |
|
|
2024
Q4 | $245K | Buy |
471
+5
| +1% | +$2.6K | 0.05% | 206 |
|
|
2024
Q3 | $288K | Hold |
466
| – | – | 0.06% | 174 |
|
|
2024
Q2 | $258K | Sell |
466
-1,210
| -72% | -$669K | 0.06% | 198 |
|
|
2024
Q1 | $974K | Buy |
1,676
+27
| +2% | +$15.7K | 0.23% | 119 |
|
|
2023
Q4 | $875K | Buy |
1,649
+14
| +0.9% | +$7.43K | 0.22% | 128 |
|
|
2023
Q3 | $828K | Buy |
1,635
+16
| +1% | +$8.1K | 0.24% | 115 |
|
|
2023
Q2 | $845K | Sell |
1,619
-48
| -3% | -$25K | 0.23% | 116 |
|
|
2023
Q1 | $961K | Buy |
1,667
+20
| +1% | +$11.5K | 0.28% | 88 |
|
|
2022
Q4 | $907K | Sell |
1,647
-54
| -3% | -$29.7K | 0.29% | 73 |
|
|
2022
Q3 | $863K | Sell |
1,701
-5
| -0.3% | -$2.54K | 0.28% | 94 |
|
|
2022
Q2 | $927K | Sell |
1,706
-1,116
| -40% | -$606K | 0.27% | 96 |
|
|
2022
Q1 | $1.67M | Sell |
2,822
-36
| -1% | -$21.3K | 0.33% | 92 |
|
|
2021
Q4 | $1.91M | Buy |
2,858
+7
| +0.2% | +$4.67K | 0.4% | 81 |
|
|
2021
Q3 | $1.63M | Sell |
2,851
-35
| -1% | -$20K | 0.34% | 96 |
|
|
2021
Q2 | $1.46M | Buy |
2,886
+417
| +17% | +$210K | 0.3% | 101 |
|
|
2021
Q1 | $1.13M | Sell |
2,469
-2,617
| -51% | -$1.19M | 0.27% | 101 |
|
|
2020
Q4 | $2.37M | Sell |
5,086
-64
| -1% | -$29.8K | 0.63% | 50 |
|
|
2020
Q3 | $2.38M | Buy |
5,150
+129
| +3% | +$59.5K | 0.68% | 44 |
|
|
2020
Q2 | $1.82M | Sell |
5,021
-148
| -3% | -$53.6K | 0.63% | 55 |
|
|
2020
Q1 | $1.77M | Sell |
5,169
-1,355
| -21% | -$464K | 0.75% | 48 |
|
|
2019
Q4 | $2.12M | Buy |
+6,524
| New | +$2.12M | 0.74% | 33 |
|